This message contains images. If you don't see images, click here to view.
Advertise in this news brief.


Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit July 24, 2014

   NAMCP   AAMCN    AAIHDS    Conferences    JMCM    Contact Us  

Fall Managed Care Forum
Nov. 13-14, 2014
Bellagio Hotel
Las Vegas Nevada

Click here to visit the conference website.

Click Here to view the Journal of Managed Care Medicine

Click Here to view our Complimentary Online CME/CEU Webcasts

 



Fall Managed Care Forum 2014

The Fall Forum will be held November, 12-13, 2014 at the Bellagio Resort in Las Vegas, Nevada for medical directors, nurses and administrators.

The Forum features up-to-date, useful information on the ACA and healthcare changes, trends and how to improve patient outcomes.

Click here to see the agenda, speakers, register and for more information on the conference.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




GENOMICS


Investigators identify genes that contribute to radiation resistance
Phys.org
A team of researchers from the University of Wisconsin have identified 46 genes in Escherichia coli that are necessary for its survival at exceptionally high levels of radiation. The paper appears ahead of print in the Journal of Bacteriology. "The research has revealed new pathways of cellular self-repair, including DNA pathways that in humans that may help protect us from cancer," says corresponding author Michael M. Cox.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Harvard scientists want gene-manipulation debate
The Boston Globe
A powerful new technology could be used to manipulate nature by “editing” the genes of organisms in the wild, enabling researchers to block mosquitoes’ ability to spread malaria, for example, or to make weeds more vulnerable to pesticides, Harvard scientists said.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


Common genes linked to autism
Psych Central
New research sheds light on autism as scientists discover most of the genetic risk for the disorder comes from versions of genes that are common in the population rather than from rare variants or spontaneous mutations. In the largest study of its kind to date, heritability outweighed other risk factors.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


BIOTECH/DIAGNOSTICS/PERSONALIZED MEDICINE


Personalized medicine proponents focus on patients, insurers
Genetic Engineering & Biotechnology News
Fulfilling the promise of personalized medicine will require more patient education, greater access to treatments, and new commitments by insurers to pay for the new drugs, an umbrella group that represents more than 200 academic, industry, patient, provider and payer communities.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Now Available


CLICK HERE to learn more about Orenitram.



Orenitram is a trademark of United Therapeutics. © 2014 United Therapeutics.
US/ORE/JUN14/038 All rights reserved.
 


Personalized medicine: It may be high cost, but it's higher value
MedCity News
Personalized medicine will be expensive in these early days of pioneering and planning. But individual genomic testing is not going to be exorbitant forever — and the ROI is gonna be big, both in patient outcomes and dollars saved, said a panel of speakers at MedCity's CONVERGE conference in Philadelphia.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


REGENERATIVE MEDICINE


Stem cell therapy could lead to HIV cure
SFGate
Two teams of scientists with strong ties to the Bay Area are racing to develop a stem cell therapy that would provide a practical cure for people living with HIV infection, leaving them with an immune system capable of keeping them healthy without daily medication even as some virus remains circulating in their bloodstream.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
What is Solesta?

What does a good day mean for your patients?

LEARN MORE
Advertise here!

To find out how to feature your company in the GBEMTI eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
MORE


Stem cells aid muscle repair and strengthening after resistance exercise
Bioscience Technology
A new study in mice reveals that mesenchymal stem cells help rejuvenate skeletal muscle after resistance exercise. By injecting MSCs into mouse leg muscles prior to several bouts of eccentric exercise, researchers were able to increase the rate of repair and enhance the growth and strength of those muscles in the exercising mice.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


EMERGING MEDICAL TECHNOLOGIES


The creative intersection of medicine and technology
iHealthBeat
Medicine is not often thought of as a creative industry. We focus instead on science and evidence. Behind the science is a group of driven individuals who are focused on problem solving. The patient's chart is a collection of information and a record of the thoughts and decisions of those who interact with that patient.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


IBM-Apple partnership could have big health IT impact
Modern Healthcare
IBM's plan to partner with Apple could prove significant for healthcare, addressing issues of data security that have stood in the way of the expansion of mobile healthcare usage and development. The partnership announced "does deliver on the promise of being able to connect the healthcare systems to the patient, to the consumer, in a new way," Dan Pelino, IBM's general manager of the public sector, said in an interview.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Big data peeps at your medical records to find drug problems
NPR
No one likes it when a new drug in people's medicine cabinets turns out to have problems — just remember the Vioxx debacle a decade ago, when the painkiller was removed from the market over concerns that it increased the risk of heart attack and stroke. To do a better job of spotting unforeseen risks and side effects, the Food and Drug Administration is trying something new — and there's a decent chance that it involves your medical records.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




FEATURED ARTICLE
TRENDING ARTICLE
MOST POPULAR ARTICLE
Investigators identify genes that contribute to radiation resistance
Phys.org
A team of researchers from the University of Wisconsin have identified 46 genes in Escherichia coli that are necessary for its survival at exceptionally high levels of radiation.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Research: Human friendships based on genetic similarities beyond the superficial
The Washington Post
Friends often look alike. The tendency of people to forge friendships with people of a similar appearance has been noted since the time of Plato.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
How DNA scissors can perform surgery directly on your genes
Popular Science
Jay Johnson's DNA was cut into pieces. Tiny molecular scissors chopped it into slices the cell couldn’t readily repair. The cell did its best at a speedy patch-up job, but the gene was left effectively useless.

Share on FacebookTwitterShare on LinkedinE-mail article
read more


FDA: NEW TREATMENTS AND TECHNOLOGY


FDA committee to discuss adverse effects of testosterone products
Reuters via Business Insider
The U.S. Food and Drug Administration has called an advisory committee meeting on Sept. 17, to discuss the adverse cardiovascular outcomes with the usage of testosterone replacement therapy. The FDA has called for a joint meeting of the bone, reproductive and urologic drugs advisory committee and the drug safety and risk management advisory committee.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Boehringer's lung drug wins FDA 'breakthrough' tag
FierceBiotech
Boehringer Ingelheim's treatment for a rare and deadly lung disease picked up the FDA's coveted breakthrough therapy designation, a mark that guarantees a speedy regulatory review and could help the company beat its nearest rival to market. The drug, dubbed nintedanib, is a therapy for idiopathic pulmonary fibrosis, an often fatal disease that scars the lungs and stands in the way of oxygen absorption.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ACCOUNTABLE CARE ORGANIZATIONS


Study: Health IT critical to success of ACOs
Health Data Management
Strong leadership, reliable healthcare coordination, and first-rate information technology are key for academic medical centers seeking to establish successful accountable care organizations, according to a Johns Hopkins Medicine study published in the journal Academic Medicine.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ACOs leverage data analytics for quality care
FierceHealthPlayer
Data analytics are a necessary ingredient for insurers creating accountable care organizations because they're key to helping providers improve the quality of care they deliver to ACO participants. Salt Lake City-based Intermountain Healthcare collects data from its clinical and financial systems to create "data marts" that focus on certain areas of analysis, reported Health Data Management.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MANAGED HEALTHCARE NEWS


Hobby Lobby: Progestins and the politics of prevention
By Jason Poquette
I would rather talk about progestins than politics almost any day of the week — they are far more predictable and cause less constipation and nausea. But the recent decision by the Supreme Court concerning Hobby Lobby and whether they have the right to not cover certain specific types of contraception has gotten so much attention from the media that silence seems almost sinful. Progestins and politics have come together. As a pharmacist and U.S. citizen, I suppose it is incumbent upon me to say something.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Taxpayers who bought health insurance through the marketplace may need a checkup
Forbes
Did you sign up for health insurance through the Health Insurance Marketplace? If so, it might be time for a mid-year checkup — of the financial sort. Beginning this year, if you get your health insurance coverage through the Health Insurance Marketplace, you may be eligible for the premium tax credit.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Big brother is watching — your waistline
POLITICO
Data mining is digging into your health. Actuaries predict your life span. Banks track your spending habits. Now, your employer can tell whether you'll have diabetes a year from now. And the federal government is encouraging businesses to use that information to tell you how to eat and exercise, to "data mine" for your own good and the employer’s bottom line.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FAST FACTS
"Seizures can be caused by a number of factors, including epilepsy or fever, and most seizures stop themselves, according to the National Institutes of Health."


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Stem cell treatment causes nasal growth in woman's back (New Scientist)
This startup will make you a personalized health plan based on your genes (Fast Company)
Defining accountable care in the age of ACOs (Health Data Management)
Adipose stem cells: Potential option for female SUI (Medscape)

Don't be left behind. Click here to see what else you missed.
 

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2635
Download media kit

Natalie Rodriguez, Senior Content Editor, 469.420.2635   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
July 17, 2014
July 10, 2014
July 3, 2014
June 26, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063